Drotaverine to shorten the duration of labour in primigravidas: a randomised, double-blind, placebo-controlled trial
African Health Sciences; 22 (3), 2022
Background: Drotaverine, a spasmolytic, has been found to have potential to achieve a reduction in the duration of labor and prevent prolonged labor.
Objective: To compare the effects of intravenous drotaverine hydrochloride with placebo for shortening the duration of active phase of labor in primigravid...